e l f Beauty Inc vs HCA Health Inc — how do they compare? e l f Beauty Inc trades at $108.42 (market cap $6.25B), while HCA Health Inc trades at $448.62 (market cap $96.35B). The key difference: HCA Health Inc is far larger — about 15.4× e l f Beauty Inc's market cap, and HCA Health Inc pays a 0.7% dividend while e l f Beauty Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold e l f Beauty Inc for 25 Days and HCA Health Inc for 76 Days on average.
| ELF | HCA | |
|---|---|---|
Market Cap | $6.25B | $96.35B |
Volume | 1,099,552 | 1,079,453 |
Sector | Consumer Staples | Health |
52-Week High | $144.97 | $545.13 |
52-Week Low | $49.57 | $361.32 |
Typical Hold Time | 25 Days | 76 Days |
Enterprise Value | $6.84B | $146.88B |
Dividend Yield | — | 0.7% |
Signals from Pluang's Aura AI — not financial advice
ELF Beauty trades at $107.95, up 2.78% with bullish technical signals and strong earnings beats. The stock shows robust revenue growth reaching $1.31B in 2025, though net margins compressed to 3.38% in 2026. Recent expansion includes rhode brand launches in Europe via Sephora and innovative marketing through original music albums. Analyst sentiment leans positive with 48% buy ratings despite a consensus price target of $95.91 below current levels.
Outlook remains growth-focused with international expansion driving opportunities, but premium valuation (P/E 108) and margin pressure pose risks. Institutional accumulation and technical strength support near-term upside, though investors should monitor execution on global growth initiatives against high expectations.
HCA Healthcare (HCA) trades at $439.17, up 1.61% today, with a bullish technical signal and strong fundamental performance. Revenue grew to $75.6 billion in 2025, with net income reaching $6.78 billion, and the company has beaten EPS estimates for three consecutive quarters. Recent news includes an upcoming Q3 2026 earnings call and the completion of the College of Health Care Professions acquisition, highlighting operational expansion.
The outlook remains positive with a consensus price target of $461.12, though risks include ongoing legal investigations and high debt levels. Earnings growth and cost controls support upside potential, but investors should monitor regulatory developments and payer-mix pressures that could impact margins.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
e.l.f. Beauty is a leading cosmetics company offering high-quality, 100% vegan, and cruelty-free products. It is known for its affordable and prestige-quality makeup and skincare items for a diverse global audience.
Read more on ELF →HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2021, the firm owned and operated 182 hospitals, 125 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England.
Read more on HCA →